Product Specification
| Host |
Mouse |
| Antigen |
CD40 |
| Synonyms |
Tumor necrosis factor receptor superfamily member 5; B-cell surface antigen CD40; Bp50; CD40L receptor; CDw40; TNFRSF5 |
| Location |
Secreted, Cell membrane |
| Accession |
P25942 |
| Clone Number |
S-R485 |
| Antibody Type |
Mouse mAb |
| Isotype |
IgG2b |
| Application |
FCM |
| Reactivity |
Hu |
| Positive Sample |
human PBMC |
| Purification |
Protein A |
| Concentration |
0.1mg/ml |
| Conjugation |
Alexa Fluor® 488 |
| Physical Appearance |
Liquid |
| Storage Buffer |
PBS, 25% Glycerol, 1% BSA, 0.3% Proclin 300 |
| Stability & Storage |
12 months from date of receipt / reconstitution, 2 to 8 °C as supplied. |
Dilution
| application |
dilution |
species |
| FCM |
5 μl per million cells in 100μl volume |
Hu |
Background
CD40, also known as TNFRSF5, is a type I transmembrane glycoprotein and a member of the tumor necrosis factor receptor superfamily. It is primarily expressed on antigen-presenting cells such as B cells, dendritic cells, and monocytes, and plays a pivotal role in the regulation of immune responses. The interaction of CD40 with its ligand, CD40L (CD154), is crucial for T cell activation, B cell proliferation, and the induction of humoral immunity. CD40 signaling is also involved in the maturation of dendritic cells and the promotion of cell-mediated immunity. Additionally, CD40 has been implicated in the pathogenesis of various cancers and is considered a potential target for immunotherapeutic strategies.